RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+58.11%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$8.26B
AUM Growth
+$8.26B
(+52%)
Cap. Flow
+$872M
Cap. Flow
% of AUM
10.56%
Top 10 Holdings %
Top 10 Hldgs %
46.78%
Holding
97
New
16
Increased
23
Reduced
35
Closed
10
Top Buys
| 1 |
Shattuck Labs
STTK
|
$295M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
$212M |
| 3 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
$176M |
| 4 |
AbbVie
ABBV
|
$149M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$94.1M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$275M |
| 2 |
Amicus Therapeutics
FOLD
|
$56.7M |
| 3 |
Boston Scientific
BSX
|
$54.3M |
| 4 |
BioNTech
BNTX
|
$53.4M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$37.8M |
Sector Composition
| 1 | Healthcare | 95.01% |
| 2 | Technology | 0.52% |
| 3 | Financials | 0.46% |
| 4 | Consumer Staples | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
26
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $94.1M | 1.14% |
+815,681
| New | +$94.1M |
|
27
Nurix Therapeutics
NRIX
$723M
| $93.6M | 1.13% |
2,846,125
+252,555
| +10% | +$8.3M |
|
28
Atea Pharmaceuticals
AVIR
$275M
| $93.2M | 1.13% |
+2,231,710
| New | +$93.2M |
|
29
Repare Therapeutics
RPTX
$73.9M
| $90.8M | 1.1% |
2,647,696
+242,722
| +10% | +$8.33M |
|
|
KLRS
30
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $89.4M | 1.08% |
2,325,595
-7,795
| -0.3% | -$300K |
|
|
TCRR
31
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $87.6M | 1.06% |
2,832,888
+39,600
| +1% | +$1.22M |
|
32
Annexon
ANNX
$225M
| $86.3M | 1.05% |
3,448,030
+5,908
| +0.2% | +$148K |
|
33
ALX Oncology
ALXO
$54.6M
| $82.8M | 1% |
960,400
+553,000
| +136% | +$47.7M |
|
34
Cigna
CI
$80.2B
| $79.8M | 0.97% |
383,093
-13,600
| -3% | -$2.83M |
|
35
UnitedHealth
UNH
$279B
| $78.8M | 0.95% |
+224,639
| New | +$78.8M |
|
36
Elevance Health
ELV
$72.4B
| $78.5M | 0.95% |
+244,332
| New | +$78.5M |
|
37
Pliant Therapeutics
PLRX
$105M
| $77M | 0.93% |
3,388,376
-3,381
| -0.1% | -$76.8K |
|
|
NVRO
38
DELISTED
NEVRO CORP.
NVRO
| $76.8M | 0.93% |
443,909
-15,700
| -3% | -$2.72M |
|
|
IMGN
39
DELISTED
Immunogen Inc
IMGN
| $67.9M | 0.82% |
10,528,179
+50,300
| +0.5% | +$324K |
|
|
GNMK
40
DELISTED
GenMark Diagnostics, Inc
GNMK
| $66.2M | 0.8% |
4,537,400
-176,200
| -4% | -$2.57M |
|
41
Akero Therapeutics
AKRO
$3.65B
| $59.9M | 0.73% |
2,322,557
-13,800
| -0.6% | -$356K |
|
|
EIDX
42
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $59.5M | 0.72% |
452,295
-13,910
| -3% | -$1.83M |
|
43
Neurogene
NGNE
$284M
| $58.3M | 0.71% |
4,131,869
-40,817
| -1% | -$576K |
|
44
Biogen
BIIB
$20.8B
| $53M | 0.64% |
216,247
-111,200
| -34% | -$27.2M |
|
45
ICU Medical
ICUI
$3.06B
| $51.8M | 0.63% |
241,454
+83,400
| +53% | +$17.9M |
|
46
Zymeworks
ZYME
$1.07B
| $51.4M | 0.62% |
1,088,300
-13,300
| -1% | -$629K |
|
47
Celldex Therapeutics
CLDX
$1.57B
| $47.5M | 0.58% |
2,711,616
+722,416
| +36% | +$12.7M |
|
|
48
BioNTech
BNTX
$24.1B
| $47.3M | 0.57% |
580,746
-654,899
| -53% | -$53.4M |
|
49
Uber
UBER
$194B
| $42.5M | 0.51% |
+833,845
| New | +$42.5M |
|
|
BCEL
50
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $40M | 0.48% |
2,476,068
-72,100
| -3% | -$1.16M |
|